1

DAFTAR PUSTAKA

Aldilla, D., 2008, Analisis Efektivitas-Biaya Penggunaan Terapi Tunggal

Biguanid Dan Sulfonilurea Pada Pasien Diabetes Mellitus Tipe 2 Rawat
Jalan Di RSUD Sleman Yogyakarta Tahun 2007-2008, Skripsi, Fakultas
Farmasi, Universitas Islam Indonesia, Yogyakarta.
American Diabetes Association, 2014, Standards of Medical Care in Diabetes-
2014. Diabetes Care, Vol. 37 (1): S14.
American Diabetes Association, 2015, Standards of Medical Care in Diabetes-
2015. Diabetes Care, Vol. 38.
Andayani, T., 2013, Farmakoekonomi Prinsip dan Metodologi, Yogyakarta:
Bursa Ilmu.
Berger, M.L., Bingefors, K., Hedblom, E., Pashos, C.L., Torrance, G., Smith,
M.D., 2003, Health Care Cost, Quality, and Outcomes : ISPOR Book of
Terms, ISPOR: USA.
Dipiro J.T., Talbert R.L., Yee G.C., Matzke G.R., Wells B.G. and Posey L.M.,
2011, Pharmacotherapy: A Pathophysiologic Approach, 8th ed., Mc Graw
Hill, United State of America.
Fares H., Dinicolantonio J.J., O’Keefe J.H. and Lavie C.J., 2016, Amlodipine in
hypertension: a first-line agent with efficacy for improving blood pressure
and patient outcomes, Open Heart, 3 (2), 473.
Gu S., Tang Z., Shi L., Sawhney M., Hu H. and Dong H., 2015, Cost-
Minimization Analysis of Metformin and Acarbose in Treatment of Type 2
Diabetes, Value in Health Regional Issues, 6, 84–88.
Hartanto, D., 2017, Gambaran Biaya Pasien Diabetes Melitus Tipe 2 Dengan
Terapi Antidiabetik Oral Di RSUD Ulin Banjarmasin, Skripsi, Universitas
Muhammadiyah Banjarmasin.
Irawan, D., 2010, Prevalensi dan Faktor Risiko Kejadian Diabetes Melitus Tipe 2
di Daerah Urban Indonesia (Analisa Data Sekunder Riskesdas 2007),
Thesis, Universitas Indonesia.
Janis, N., 2014, Supply, dan Demand Terhadap Layanan
Kesehatan,http://www.kemenkeu.go.id/sites/default/files/2014_kajian_pprf
_BPJS.pdf (diunduh tanggal 26 September 2016).
Kementrian Kesehatan Republik Indonesia, 2013, Pedoman Penerapan Kajian
Farmakoekonomi, Direktorat Jenderal Bina Kefarmasian dan Alat
Kesehatan, Jakarta.
Kementerian Kesehatan Republik Indonesia, 2014, Profil kesehatan Kabupaten
Sukoharjo Tahun 2014, Sukoharjo.
 2

Kumar, S., and Baldi, A., 2013, Pharmacoeconomics: Principles, Methods and
Economic Evaluation of Drug Therapies, Department of Quality
Assurance, I. S. F, College of Pharmacy: India.
Koda-Kimble, M.A., Young L.Y. and Alldredge B.K., 2008, Applied
Therapeutics. The Clinical Use Of Drug. 9 th, Lippincot Williams &
Wilkins: Philadelpia.
Melorose J., Perroy R. and Careas S., 2015, Pengelolaan dan Pencegahan
Diabetes Melitus Tipe 2 di Indonesia, Statewide Agricultural Land Use
Baseline 2015, 1, 3–7.
Murni, 2010, Analisis Efektivitas Biaya pada Penderita Diabetes Melitus tipe 2
Rawat inap Peserta Asuransi Kesehatan di Rumah Sakit Dr. Moewardi
Surakarta tahun 2014, Skripsi, Fakultas Farmasi, Universitas
Muhammadiyah, Surakarta.
National Center for Chronic Disease Prevention and Health Promotion, 2014,
National Diabetes Statistics Report , 2014 Estimates of Diabetes and Its
Burden in the Epidemiologic estimation methods, US Department of
Health and Human Services.
National Institute of Health, 2014, Causes of Diabetes, National Diabetes
Information, United States of America.
PERKENI, 2015, Pengelolaan dan Pencegahan Diabetes Melitus Tipe 2 di
Indonesia, PERKENI, Jakarta.
Price, S. A. And Wilson, L, M., 2005, Patofisiologi: Konsep Klinis Proses-Proses
Penyakit, edisi 6, EGC: Jakarta.
Priharsi. A., 2015. Analisi Efektivitas Biaya Antidibetik Oral pada Penderita
Diabetes Melitus Tipe 2 Rawat inap Peserta BPJS di Rumah Sakit Umum
Daerah DR. Moewardi Tahun 2014, Skripsi, Fakultas Farmasi, Universitas
Muhammadiyah Surakarta, Surakarta.
Rascati, K, L., 2009, Essential of Pharmacoeconomics, Walters Kluwer Health:
Philadelphia.
Triplitt C.L., Reasner C.A. and Isley W.L., 2008, Diabetes Mellitus, Dalam
Pharmacotherapy Handbook, The McGraw-Hill Companies, United States
of America, pp. 1205–1241
UU BPJS, 2011, Penjelasan Tentang BPJS, www.djpp.kemenkumham.go.id
(diunduh pada tanggal 16 November 2016).
Wild, S., Roglic, G., Green, A., Sicree, R., & King, H., 2004, Global Prevalence
of Diabetes: Estimates for the year 2000 and projections for 2030,
Diabetes Care, 27, 1047-1053.